Coronary sinus electrode does not reduce atrial defibrillation thresholds

Heart Rhythm

Volumn 3, Issue 6, 2006, Pages 647-652

  Rashba, Eric J ^a   Shorofsky, Stephen R ^a   Scheiner, Avram ^b   Peters, Robert W ^a,b,c   Ma, Carol ^a,b,c   Gold, Michael R ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Atrial fibrillation; Implantable cardioverter defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY SINUS; DEFIBRILLATION; ELECTRODE; FEMALE; HEART ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SINUS RHYTHM; SUPERIOR CAVA VEIN; TREATMENT INDICATION;

ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33646799128     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.02.1029     Document Type: Article

References (31)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G., and Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
3. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., and Heo M. Improved survival with an implanted defibrillator in patients with coronary artery disease at risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
4. Moss A.J., Zareba W.J., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Kadish A., Dyer A., Daubert J.P., Quigg R., Estes N.A., Anderson K.P., Calkins H., Hoch D., Goldberger J., Shalaby A., Sanders W.E., Schaechter A., Levine J.H., and Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
6. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domansk M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., Ip J.H., and Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
7. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., DeMarco T., Carson P., DiCarlo L., DeMets D., White W.G., DeVries D.W., Feldman A.M., Comparison of Medical Therapy, Pacing, and and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
8. Best P.J.M., Hayes D.L., and Stanton M.S. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. PACE 22 (1999) 79-85
9. Gronefeld G.C., Mauss O., Li Y.G., Klingenheben T., and Hohnloser S.H. Association between atrial fibrillation and appropriate implantable cardioverter-defibrillator therapy. results from a prospective study. J Cardiovasc Electrophysiol 11 (2000) 1208-1214
10. Stein K.M., Euler D.E., Mehra R., Seidl K., Slotwiner D.J., Mittal S., Markowitz S.M., Lerman B.B., and Jewel AF Worldwide Investigators. Do atrial tachyarrhythmias beget ventricular tachycarrhythmias in defibrillator recipients?. J Am Coll Cardiol 40 (2002) 335-340
11. Daoud E.G., Timmermans C.M., Fellows C., Hoyt R., Lemery R., Dawson K., Ayers G.M., and Metrix Investigators. Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Circulation 102 (2000) 1407-1413
12. Wellens H.J.J., Lau C.P., Luderitz B., Akhtar M., Waldo A.L., Camm A.J., Timmermans C., Tse H.F., Jung W., Jordaens L., and Ayers G. Atrioverter. An implantable device for the treatment of atrial fibrillation. Circulation 98 (1998) 1651-1656
13. Gold M.R., Sulke N., Schwartzman D.S., Mehra R., Euler D.E., and Worldwide Jewel AF-Only Investigators. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial arrhythmias. J Cardiovasc Electrophysiol 12 (2001) 1247-1253
14. Swerdlow C.D., Schwartzman D., Hoyt R., Bailin S.J., Koehler J.L., Warman E.N., and Worldwide Model 7250 Jewel AF-Only Investigators. Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 13 (2002) 347-354
15. Boriani G., Wollman C., Biffi M., Kuhl M., Schuchert A., Sperzel J., Stiller S., Gasparini G., and Bocker D. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias. PACE 26 Pt. II (2003) 461-465
16. Cooklin M., Olsovsky M.R., Brockman R.G., Shorofsky S.R., and Gold M.R. Atrial defibrillation with a transvenous lead. A randomized comparison of active can shocking pathways. J Am Coll Cardiol 34 (1999) 358-362
17. Gold M.R., Shorofsky S.R., Bouhouch R., Joy R.A., Kirby D.S., Osman A.F., and Rashba E.J. Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 13 (2002) 332-335
18. Rashba E.J., Shorofsky S.R., Peters R.W., and Gold M.R. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol 15 (2004) 790-794
19. Gold M.R., Olsovsky M.R., Pelini M.A., Peters R.W., and Shorofsky S.R. A comparison of single and dual coil active pectoral defibrillation lead systems. J Am Coll Cardiol 31 (1998) 1391-1394
20. Cooper R.A., Johnson E.E., and Wharton J.M. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms - the importance of phase duration. Circulation 95 (1997) 1487-1496
21. Cooper R.A.S., Plumb V.J., Epstein A.E., Kay N.G., and Ideker R.E. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans. Circulation 97 (1998) 2527-2535
22. Benser M.E., Walcott G.P., Killingsworth C.R., Girouard S.D., Morris M.M., and Ideker R.E. Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator. J Cardiovasc Electrophysiol 12 (2001) 57-864
23. Tse H.F., Timmermans C., Rodriguez L.-M., Lau C.-P., and Wellens H.J.J. Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator. J Cardiovasc Electrophysiol 14 (2003) 32-37
24. Steinhaus D.M., Cardinal D.S., Mongeon L., Musley S.K., Foley L., and Corrigan S. Internal defibrillation. pain perception of low energy shocks. Pacing Clin Electrophysiol 25 (2002) 1090-1093
25. Timmermans C., Rodriguez L.-M., Ayers G.M., Lambert H., Smeets J.L.R.M., Vlaeyen J.W.S., Albert A., and Wellens H.J.J. Effects of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation 99 (1999) 1837-1842
26. Lau C.P., and Nok N.S. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation. PACE 20 (1997) 2442-2452
27. Timmermans C., Rodriguez L.-M., Ayers G.M., Lambert H., Smeets J.L.R.M., and Wellens H.J.J. Effect of electrode length on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 9 (1998) 582-587
28. Strickberger S.A., Man K.C., Souza J., Zivin A., Weiss R., Knight B.P., Goyal R., Daoud E.G., and Morady F. A prospective evaluation of two defibrillation safety margin techniques in patients with low defibrillation energy requirements. J Cardiovasc Electrophysiol 9 (1998) 41-46
29. Singer I., and Lang D. Defibrillation threshold. clinical utility and therapeutic implications. PACE 15 (1992) 932-949
30. McDaniel W.C., and Schuder J.C. The cardiac ventricular defibrillation threshold-inherent limits in its application and interpretation. Med Instrum 21 (1987) 170-176
31. Boriani G., Bartolini P., Biffi M., Calcagnini G., Camanini C., Corazza I., Zannoli R., Barbaro V., and Branzi A. Atrial signal analysis and defirbrillation threshold assessment in chronic persistent and reinduced atrial fibrillation. J Cardiovasc Electrophysiol 13 (2002) 449-454